To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
Sustainability-related
disclosures
Contact
.
News
Vesalius News
09/03/2025
Scenic Biotech publishes in Nature
read more
08/26/2025
Scenic: License and Research Agreement
read more
08/19/2025
Memo Therapeutics: Phase I Study
read more
.
xxnoxx_zaehler